Preclinical Study Data on TTX-MC138 for Glioblastoma Accepted for Publication
source: shutterstock.com

Preclinical Study Data on TTX-MC138 for Glioblastoma Accepted for Publication

TransCode Therapeutics, Inc. (“TransCode”) was founded with a mission to revolutionize the cancer treatment landscape and improve patient outcomes. The company is currently working to uphold this mission through the…

Continue Reading Preclinical Study Data on TTX-MC138 for Glioblastoma Accepted for Publication